These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 33692425)

  • 1. Cost-effectiveness of percutaneous coronary intervention versus medical therapy in patients with acute myocardial infarction: real-world and lifetime-horizon data from Taiwan.
    Liao CT; Hsieh TH; Shih CY; Liu PY; Wang JD
    Sci Rep; 2021 Mar; 11(1):5608. PubMed ID: 33692425
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cardiologist service volume, percutaneous coronary intervention and hospital level in relation to medical costs and mortality in patients with acute myocardial infarction: a nationwide study.
    Liu CY; Lin YN; Lin CL; Chang YJ; Hsu YH; Tsai WC; Kao CH
    QJM; 2014 Jul; 107(7):557-64. PubMed ID: 24570479
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cost-effectiveness of percutaneous coronary intervention versus bypass surgery from a Dutch perspective.
    Osnabrugge RL; Magnuson EA; Serruys PW; Campos CM; Wang K; van Klaveren D; Farooq V; Abdallah MS; Li H; Vilain KA; Steyerberg EW; Morice MC; Dawkins KD; Mohr FW; Kappetein AP; Cohen DJ;
    Heart; 2015 Dec; 101(24):1980-8. PubMed ID: 26552756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents versus bypass surgery for patients with 3-vessel or left main coronary artery disease: final results from the Synergy Between Percutaneous Coronary Intervention With TAXUS and Cardiac Surgery (SYNTAX) trial.
    Cohen DJ; Osnabrugge RL; Magnuson EA; Wang K; Li H; Chinnakondepalli K; Pinto D; Abdallah MS; Vilain KA; Morice MC; Dawkins KD; Kappetein AP; Mohr FW; Serruys PW;
    Circulation; 2014 Sep; 130(14):1146-57. PubMed ID: 25085960
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Differential time trends of outcomes and costs of care for acute myocardial infarction hospitalizations by ST elevation and type of intervention in the United States, 2001-2011.
    Sugiyama T; Hasegawa K; Kobayashi Y; Takahashi O; Fukui T; Tsugawa Y
    J Am Heart Assoc; 2015 Mar; 4(3):e001445. PubMed ID: 25801759
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A medical costs study of older patients with acute myocardial infarction and metabolic syndrome in hospital.
    Fan GQ; Fu KL; Jin CW; Wang XZ; Han L; Wang H; Zhong M; Zhang Y; Zhang W; Wang ZH
    Clin Interv Aging; 2015; 10():329-37. PubMed ID: 25670890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Frequency of 30-day readmission and its causes after percutaneous coronary intervention in acute myocardial infarction complicated by cardiogenic shock.
    Atti V; Patel NJ; Kumar V; Tripathi B; Basir MB; Voeltz M; Baber U; Kini AS; Sharma SK; O'Neill WW; Bhatt DL
    Catheter Cardiovasc Interv; 2019 Aug; 94(2):E67-E77. PubMed ID: 30811833
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Impacts of health insurance benefit design on percutaneous coronary intervention use and inpatient costs among patients with acute myocardial infarction in Shanghai, China.
    Yuan S; Liu Y; Li N; Zhang Y; Zhang Z; Tao J; Shi L; Quan H; Lu M; Ma J
    Pharmacoeconomics; 2014 Mar; 32(3):265-75. PubMed ID: 23975740
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-effectiveness of percutaneous coronary intervention with drug-eluting stents in patients with multivessel coronary artery disease compared to coronary artery bypass surgery five-years after intervention.
    Krenn L; Kopp C; Glogar D; Lang IM; Delle-Karth G; Neunteufl T; Kreiner G; Kaider A; Bergler-Klein J; Khorsand A; Nikfardjam M; Laufer G; Maurer G; Gyöngyösi M
    Catheter Cardiovasc Interv; 2014 Dec; 84(7):1029-39. PubMed ID: 24403120
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The temporal trends of incidence, treatment, and in-hospital mortality of acute myocardial infarction over 15years in a Taiwanese population.
    Yin WH; Lu TH; Chen KC; Cheng CF; Lee JC; Liang FW; Huang YT; Yang LT
    Int J Cardiol; 2016 Apr; 209():103-13. PubMed ID: 26889592
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical Characteristics of Patients With Acute Myocardial Infarction Who Did Not Undergo Primary Percutaneous Coronary Intervention- Report From the MIYAGI-AMI Registry Study.
    Hao K; Takahashi J; Ito K; Miyata S; Nihei T; Nishimiya K; Tsuburaya R; Matsumoto Y; Sakata Y; Yasuda S; Shimokawa H;
    Circ J; 2015; 79(9):2009-16. PubMed ID: 26118344
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Coronary bypass surgery versus percutaneous coronary intervention: cost-effectiveness in Iran: a study in patients with multivessel coronary artery disease.
    Javanbakht M; Bakhsh RY; Mashayekhi A; Ghaderi H; Sadeghi M
    Int J Technol Assess Health Care; 2014 Oct; 30(4):366-73. PubMed ID: 25401422
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and cost-effectiveness of facilitated percutaneous coronary intervention compared with primary percutaneous coronary intervention in patients with ST-segment elevation myocardial infarction transferred from community hospitals.
    Coleman CI; McKay RG; Boden WE; Mather JF; White CM
    Clin Ther; 2006 Jul; 28(7):1054-62. PubMed ID: 16990084
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cost-Effectiveness of Percutaneous Coronary Intervention Compared With Medical Therapy for Ischemic Heart Disease in Japan.
    Kodera S; Morita H; Kiyosue A; Ando J; Komuro I
    Circ J; 2019 Jun; 83(7):1498-1505. PubMed ID: 31168046
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cost-effectiveness of optimal use of acute myocardial infarction treatments and impact on coronary heart disease mortality in China.
    Wang M; Moran AE; Liu J; Coxson PG; Heidenreich PA; Gu D; He J; Goldman L; Zhao D
    Circ Cardiovasc Qual Outcomes; 2014 Jan; 7(1):78-85. PubMed ID: 24425706
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Economic evaluation of culprit lesion only PCI vs. immediate multivessel PCI in acute myocardial infarction complicated by cardiogenic shock: the CULPRIT-SHOCK trial.
    Robles-Zurita JA; Briggs A; Rana D; Quayyum Z; Oldroyd KG; Zeymer U; Desch S; de Waha-Thiele S; Thiele H
    Eur J Health Econ; 2020 Nov; 21(8):1197-1209. PubMed ID: 33029668
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Performance of Hospitals When Assessing Disease-Based Mortality Compared With Procedural Mortality for Patients With Acute Myocardial Infarction.
    Nathan AS; Xiang Q; Wojdyla D; Khatana SAM; Dayoub EJ; Wadhera RK; Bhatt DL; Kolansky DM; Kirtane AJ; Rao SV; Yeh RW; Groeneveld PW; Wang TY; Giri J
    JAMA Cardiol; 2020 Jul; 5(7):765-772. PubMed ID: 32347890
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Underuse of coronary intervention and its impact on mortality in the elderly with myocardial infarction. A propensity-matched analysis from the Hungarian Myocardial Infarction Registry.
    Komócsi A; Simon M; Merkely B; Szűk T; Kiss RG; Aradi D; Ruzsa Z; Andrássy P; Nagy L; Lupkovics G; Kőszegi Z; Ofner P; Jánosi A
    Int J Cardiol; 2016 Jul; 214():485-90. PubMed ID: 27100339
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparison of long-term mortality in patients with acute myocardial infarction associated with or without sepsis.
    Liu ES; Chiang CH; Hung WT; Tang PL; Hung CC; Kuo SH; Liu CP; Chen YS; Mar GY; Huang WC
    Int J Infect Dis; 2019 Feb; 79():169-178. PubMed ID: 30503653
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Comparison of outcomes in ST-segment depression and ST-segment elevation myocardial infarction patients treated with emergency PCI: data from a multicentre registry.
    Knot J; Kala P; Rokyta R; Stasek J; Kuzmanov B; Hlinomaz O; Bĕlohlavek J; Rohac FP; Petr R; Bilkova D; Djambazov S; Grigorov M; Widimsky P
    Cardiovasc J Afr; 2012 Oct; 23(9):495-500. PubMed ID: 23108517
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.